Procter & Gamble Company (The) $PG Shares Acquired by Soltis Investment Advisors LLC

Soltis Investment Advisors LLC lifted its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 39.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,378 shares of the company’s stock after acquiring an additional 25,339 shares during the period. Procter & Gamble accounts for approximately 0.6% of Soltis Investment Advisors LLC’s portfolio, making the stock its 29th biggest holding. Soltis Investment Advisors LLC’s holdings in Procter & Gamble were worth $12,985,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Founders Financial Securities LLC raised its stake in Procter & Gamble by 3.0% in the 3rd quarter. Founders Financial Securities LLC now owns 47,213 shares of the company’s stock valued at $6,859,000 after purchasing an additional 1,358 shares during the last quarter. Keeler & Nadler Financial Planning & Wealth Management purchased a new position in Procter & Gamble in the 3rd quarter valued at about $207,000. Financial Solutions Advisory Group Inc. boosted its stake in shares of Procter & Gamble by 5.5% during the 3rd quarter. Financial Solutions Advisory Group Inc. now owns 7,855 shares of the company’s stock worth $1,252,000 after purchasing an additional 410 shares during the last quarter. United Asset Strategies Inc. boosted its stake in shares of Procter & Gamble by 3.3% during the 3rd quarter. United Asset Strategies Inc. now owns 19,453 shares of the company’s stock worth $2,826,000 after purchasing an additional 619 shares during the last quarter. Finally, Fonville Wealth Management LLC boosted its stake in shares of Procter & Gamble by 62.1% during the 3rd quarter. Fonville Wealth Management LLC now owns 2,307 shares of the company’s stock worth $335,000 after purchasing an additional 884 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Analysts Set New Price Targets

PG has been the subject of a number of analyst reports. BNP Paribas Exane boosted their price objective on shares of Procter & Gamble from $177.00 to $189.00 and gave the company an “outperform” rating in a research report on Friday, October 23rd. Royal Bank Of Canada set a $169.00 price objective on shares of Procter & Gamble in a research note on Friday, October 23rd. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Procter & Gamble in a research report on Friday, October 23rd. Argus cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Finally, Evercore upgraded Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a report on Tuesday, October 6th. Fifteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $170.57.

Procter & Gamble Stock Performance

NYSE PG opened at $160.48 on Friday. The business’s 50-day moving average price is $149.62 and its 200 day moving average price is $148.85. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a market capitalization of $371.95 billion, a PE ratio of 24.17, a price-to-earnings-growth ratio of 3.89 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. The company had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.99 EPS. On average, research analysts predict that Procter & Gamble Company will post 6.99 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is presently 65.51%.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly beat supports the stock: P&G reported earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion exceeded expectations. Sales increased 4% year over year, helping reinforce confidence in the company’s growth outlook. What Did Procter & Gamble’s Latest Quarter Change for Its Stock?
• Positive Sentiment: Analyst upgrade adds support: Freedom Broker raised its rating on PG from “hold” to “buy,” signaling increased confidence in the company’s earnings durability and valuation potential. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Revenue growth and dividend appeal remain key attractions: Organic sales rose 4%, with much of the gain coming from higher product volumes. P&G’s portfolio of leading brands and long dividend history continue to appeal to income-focused investors. Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising
• Neutral Sentiment: New bond issuance highlights financing strategy: P&G tapped euro and dollar markets with fixed-rate notes, providing funding flexibility but also adding debt obligations. The issuance puts greater focus on the company’s balance sheet and already elevated valuation. Procter & Gamble Bond Sale Puts Its Pricey Valuation Narrative In Focus
• Negative Sentiment: Cost inflation and mixed ratings temper optimism: Rising commodity and operating costs could pressure margins, while DZ Bank downgraded PG from “strong-buy” to “hold.” ETF net selling also represents a modest technical headwind. How Is Procter & Gamble Handling Commodity Costs After Its Report?

Insiders Place Their Bets

In related news, CEO Paul Gama sold 4,331 shares of the company’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $161.27, for a total transaction of $698,460.37. Following the completion of the transaction, the chief executive officer owned 46,793 shares of the company’s stock, valued at approximately $7,546,307.11. This represents a 8.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Susan Whaley sold 2,369 shares of the stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the transaction, the insider directly owned 30,730 shares in the company, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 58,647 shares of company stock valued at $9,268,508. 0.23% of the stock is currently owned by corporate insiders.

Procter & Gamble Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.